RESTRICTED STOCK SUBSTITUTION AGREEMENTRestricted Stock Substitution Agreement • December 2nd, 2016 • Acucela Inc. • Pharmaceutical preparations • Tokyo
This Restricted Stock Substitution Agreement (the “Agreement”) is made and entered into as of [Month, Date], [Year], by and between Kubota Pharmaceutical Holdings Co., Ltd., a Japanese corporation (the “Company”), and [Name] (the “Holder”).
STOCK OPTION SUBSTITUTION AGREEMENTStock Option Substitution Agreement • December 2nd, 2016 • Acucela Inc. • Pharmaceutical preparations • Tokyo
This Stock Option Substitution Agreement (the “Agreement”) is made and entered into as of [Month, Date], [Year], by and between Kubota Pharmaceutical Holdings Co., Ltd., a Japanese corporation (the “Company”), and [Name] (the “Holder”).
RESTRICTED STOCK UNIT SUBSTITUTION AGREEMENTRestricted Stock Unit Substitution Agreement • December 2nd, 2016 • Acucela Inc. • Pharmaceutical preparations • Tokyo
This Restricted Stock Unit Substitution Agreement (the “Agreement”) is made and entered into as of [Month, Date], [Year], by and between Kubota Pharmaceutical Holdings Co., Ltd., a Japanese corporation (the “Company”), and [Name] (the “Holder”).
Liability Limitation AgreementLiability Limitation Agreement • December 2nd, 2016 • Acucela Inc. • Pharmaceutical preparations
Kubota Pharmaceutical Holdings Co., Ltd. (the “Company”) and [TBD] (“Director”) enter into this agreement (this “Agreement”) as follows in accordance with Article 427, Paragraph 1 of the Companies Act and Article 26, Paragraph 2 of the Articles of Incorporation of the Company.
